The influence of immunosuppressive drugs on T- and B-cell apoptosis via p53-mediated pathway in vitro and in vivo

Transplantation

Volumn 82, Issue 3, 2006, Pages 422-427

  Boldt, Andreas ^a   Barten, Markus J ^a   Sagner, Anja ^a   Mohr, Friedrich W ^a   Adams, Volker ^a   Dhein, Stefan ^a   Gummert, Jan F ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Apoptosis; Immunosuppression; Lymphocytes; Whole blood

Indexed keywords

APOPTOSIS INDUCING FACTOR; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; DACTINOMYCIN; IMMUNOSUPPRESSIVE AGENT; INOSINATE DEHYDROGENASE INHIBITOR; MYCOPHENOLIC ACID; PROTEIN P53; TACROLIMUS;

ADULT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; NICK END LABELING; PRIORITY JOURNAL; T LYMPHOCYTE;

APOPTOSIS; B-LYMPHOCYTES; CYCLOSPORINE; DACTINOMYCIN; DRUG THERAPY, COMBINATION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TACROLIMUS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33747096205     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000229036.75483.15     Document Type: Article

References (38)

1. Snanoudj R, Beaudreuil S, Arzouk N, et al. Immunological strategies targeting B cells in organ grafting. Transplantation 2005; 79: 33.
2. Costa C, Pizzolato MC, Shen Y, et al. CD86 blockade in genetically modified porcine cells delays xenograft rejection by inhibiting T-cell and NK-cell activation. Cell Transplant 2004; 13: 75.
3. Vathsala A, Chin YM, Noraiza I, Sun L. Inhibition of apoptosis in anti-CD3-treated peripheral blood lymphocytes by immunosuppressive drugs. Transplant Proc 2000; 32: 1992.
4. Hartel C, Schumacher N, Fricke L, et al. Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect. Clin Chem 2004; 50: 141.
5. Hartel C, Hammers HJ, Schlenke P, et al. Individual variability in cyclosporin A sensitivity: the assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytes. J Interferon Cytokine Res 2003; 23: 91.
6. Sindhi R, Allaert J, Gladding D, et al. Modeling individual variation in biomarker response to combination immunosuppression with stimulated lymphocyte responses-potential clinical implications. J Immunol Methods 2003; 272: 257.
7. Cohn RG, Mirkovich A, Dunlap B, et al. Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines. Transplantation 1999; 68: 411.
8. Migita K, Eguchi K, Kawabe Y, et al. FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. J Clin Invest 1995; 96: 727.
9. Genestier L, Dearden-Badet MT, Bonnefoy-Berard N, et al. Cyclosporin A and FK506 inhibit activation-induced cell death in the murine WEHI-231 B cell line. Cell Immunol 1994; 155: 283.
10. Thomson AW, Bonham CA. Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506). Its relevance to therapy of HIV infection. Adv Exp Med Biol 1995; 374: 211.
11. Takahashi Reynolds M, Ogawa N, Longo DL, Burdick J. Augmentation of T-cell apoptosis by immunosuppressive agents. Clin Transplant 2004; 18: 72.
12. Rivera A, Maxwell SA. The p53-induced Gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J Biol Chem 2005; 280: 29346.
13. Schmitz I, Kirchhoff S, Krammer PH. Regulation of death receptor-mediated apoptosis pathways. Int J Biochem Cell Biol 2000; 32: 1123.
14. Mele TS, Halloran PF. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 2000; 47: 215.
15. Allison AC, Eugui EM. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation 2005; 80: 181.
16. Park S, Ha H, Seo J, et al. Mycophenolic acid inhibits platelet-derived growth factor-induced reactive oxygen species and mitogen-activated protein kinase activation in rat vascular smooth muscle cells. Am J Transplant 2004; 4: 1982.
17. Barten MJ, Streit F, Boeger M, et al. Synergistic effects of sirolimus and tacrolimus: Analysis of immunosuppression on lymphocyte proliferation and activation in whole blood. Transplantation 2004; 77: 1154.
18. Barten MJ, Dhein S, Chang H, et al. Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood. J Immunol Methods 2003; 283: 99.
19. Suzuki S, Chuang LF, Doi RH, Chuang RY. Morphine suppresses lymphocyte apoptosis by blocking p53-mediated death signaling. Biochem Biophys Res Comm 2003; 308: 802.
20. Kasai T, Ohguchi K, Nakashima S, et al. Increased activity of oleate-dependent type phospholipase D during actinomycin-D-induced apoptosis in Jurkat T cells. J Immunol 1998; 161: 6469.
21. Mirakian R, Nye K, Palazzo FF, et al. Methods for detecting apoptosis in thyroid diseases. J Immunol Methods 2002; 265: 161.
22. Van Engeland M, Nieland LJW, Ramaekers FCS, et al. Annexin-Vaffinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998; 31: 1.
23. Ermak G, Davies KJ. Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol 2002; 38: 713.
24. Aramburu J, Rao A, Klee CB. Calcineurin: from structure to function. Curr Top Cell Regul 2000; 36: 237.
25. Shibasaki F, Kondo E, Akagi T, McKeon F. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 1997; 386: 728.
26. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 1999; 284: 339.
27. Cho CS, Elkahwaji J, Chang Z, et al. Modulation of the electrophoretic mobility of the linker for activation of T cells (LAT) by the calcineurin inhibitors CsA and FK506: LAT is a potential substrate for PKC and calcineurin signaling pathways. Cell Signal 2003; 15: 85.
28. Hortelano S, Lopez-Collazo E, Bosca L. Protective effect of cyclosporin A and FK506 from nitric oxide dependent apoptosis in activated macrophages. Br J Pharmakol 1999; 126: 1139.
29. Yarosh DB, Pena AV, Nay SL, et al. Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. J Invest Dermatol 2005; 125: 1020.
30. Hildemann DA. Regulation of T-cell apoptosis by reactive oxygen species. Free Radical Biol Med 2004; 36: 1496.
31. Tripathi P, Hildeman D. Sensitization of T cells to apoptosis-a role for ROS? Apoptosis 2004; 9: 515.
32. Bragadin M, Toninello A, Bindoli A, et al. Thallium induces apoptosis in Jurkat cells. Ann N Y Acad Sci 2003; 1010: 283.
33. Tung TC, Oshima K, Cui G, et al. Dual upregulation of Fas and Bax promotes alloreactive T cell apoptosis in IL-10 gene targeting of cardiac allografts. Am J Physiol Heart Circ Physiol 2003; 285: 964.
34. Ankersmit HJ, Moser B, Zuckermann A, et al. Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients. Clin Exp Immunol 2002; 128: 175.
35. Xu B, Sakkas L, Slachta C, et al. Apoptosis in chronic rejection of human cardiac allografts. Transplantation 2001; 27; 71(8): 1137-46.
36. Fujiwara T, Ikeda Y, Arita K, et al. The effects of immunosuppressants on FAS-mediated activation-induced cell death in human T lymphocytes. Transpl Int 2003; 16: 108.
37. Gan YH, Lui SS, Malkovsky M. Differential susceptibility of naive and activated human gammadelta T cells to activation-induced cell death by T-cell receptor cross-linking. Mol Med 2001; 7: 636.
38. Nakamura M, Ogawa N, Shalabi A, et al. Positive effect on T-cell regulatory apoptosis by mycophenolate mofetil. Clin Transplant 2001; 16: 36.